Gene Therapy Approaches to Parkinson's Disease: Preclinical to Clinical Trials, or What Steps to Take to Get There from Here?

By Redmond D.E.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 160-167

Elsevier

Access to resources Recommend Favorite

Real-Time Dynamics of Dopamine Released from Neuronal Transplants in Experimental Parkinson's Disease

By Cragg S.J.   Clarke D.J.   Greenfield S.A.  

Experimental Neurology, Vol. 164, Iss. 1, 2000-07 ,pp. : 145-153

Elsevier

Access to resources Recommend Favorite

Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease

By Raymon H.K.   Thode S.   Gage F.H.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 82-91

Elsevier

Access to resources Recommend Favorite

Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease

By Elsworth J.D.   Roth R.H.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 4-9

Elsevier

Access to resources Recommend Favorite

Targets for Gene Therapy of Parkinson's Disease: Growth Factors, Signal Transduction, and Promoters

By During M.J.   Leone P.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 74-81

Elsevier

Access to resources Recommend Favorite